 
                        CKI-7 free base NEW
| Price | $88 | 
| Package | 2mg | 
| Min. Order: | |
| Supply Ability: | 10g | 
| Update Time: | 2025-07-23 | 
Product Details
| Product Name: CKI-7 free base | CAS No.: 120615-25-0 | 
| Supply Ability: 10g | Release date: 2025/07/23 | 
Product Introduction
Bioactivity
| Name | CKI-7 free base | 
| Description | CKI-7 free base is a potent, ATP-competitive inhibitor of casein kinase 1 (CK1; IC50: 6 μM; Ki: 8.5 μM) and a selective Cdc7 kinase inhibitor, also inhibiting SGK, ribosomal S6 kinase-1 (S6K1), and MSK1. | 
| In vitro | The treatment of CKI-7 (0.1-10 μM; 5 days; ES cells) significantly increases the expression of the early neuroectodermal marker Sox1 and the number of cells positive for the neural markers βIII-tubulin and nestin, in a concentration-dependent manner. CKI-7 (5 μM; 5 days; ES cells) treatment suppresses SFEB-induced β-catenin stabilization on day 5 [1]. | 
| In vivo | In vivo dose-dependent, the anti-tumor activity of CKI-7 is demonstrated in a SCID-Beige mouse systemic tumor model utilizing isolated Philadelphia chromosome-positive acute lymphoblastic leukemia cell line. Exposure to CKI-7 results in a cell cycle-dependent caspase 3 activation and apoptotic cell death [2]. | 
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | 
| Solubility Information | DMSO : 25 mg/mL (87.49 mM), Sonication is recommended. | 
| Keywords | CKI-7 free base | CKI7 free base | CKI7 | CKI 7 free base | CKI 7 | CK1 | CaseinKinase | Casein Kinase | 
| Inhibitors Related | TBCA | CK2-IN-4 | Ellagic acid | Casein Kinase II Inhibitor IV | CK2α-IN-1 | Emodin | LY-364947 | AS-252424 | TA-01 | CK2/ERK8-IN-1 | Casein kinase 1δ-IN-6 | LY294002 | 
Company Profile Introduction
                            Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
                        
                    You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $116.00/1mg | VIP6Y | TargetMol Chemicals Inc.  | 2025-10-26 | |
| $0.00/1kg | VIP6Y | Zison Pharmaceutical (Shandong) Co., Ltd. | 2024-05-24 | |
| $0.00/25KG | VIP1Y | Shaanxi Dideu New Materials Co. Ltd | 2025-05-16 | 
- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, USA
INQUIRY
                    
 
            


 
                 
        
 
                                         
                                         
                                         
                                         
                             United States
United States